Before the arrival of the Corona vaccine, the Priority Group has been finalized in India. In the first phase, 31 crore people will be vaccinated. These include healthcare workers, police, priority group members above 50 years of age, and youth from high-risk groups. The government has also decided that the initial data from two full-shot results from two-dose trials of the Oxford-AstraZeneca vaccine will be considered.
Blueprint for vaccine preparation
Principal Scientific Advisor K. According to Vijayaraghavan, the National Vaccine Committee headed by Dr. VK Paul has prepared a blueprint for who will be the first to be vaccinated. He told a meeting of the Ministry of Science and The Confederation of Indian Industry (CII) that 31 crore people have been identified, who will be vaccinated between March and May.
Vijayaraghavan said, 'One crore health workers in our country, 2 crore of state and central government police, armed forces, home guards, civil defense, 26 crore members of priority group over 50 years of age and below 50 years 1 crore members of the high-risk group will be the first to be vaccinated. Earlier, Union Health Minister Harsh Vardhan has said that the vaccine will start from the first quarter of 2021. 25 crore people are ready to be vaccinated. 40-50 crore doses will be available by July.
What data will Oxford consider India?
Phase 3 or final phase trials of the Corona Vaccine Coveshield of Oxford University-AstraZeneca have yielded results. On giving two full doses, the FICCI was 62% and when given one half and one full dose, the FICC was 90 percent. On which of these two formulas the data will be considered in India, the head of the National Vaccine Committee, Dr. VK Paul has said that the regulators are examining the data. Whatever decision will be taken will be on a scientific basis. It is not right to make public debate on this data is confidential. At the same time, some other Indian officials say that the American Food and Drug Administration (USFDA) has required at least 50% efficacy to approve the vaccine. In this case, the results of two full dosage formulas are also good.
European Union will take its first vaccine this year
European Union leaders expect the first vaccine to be introduced in December. By the way, the European Medicines Agency, without naming any company, said that in the next few days, some companies can apply for approval. Pfizer and Biotech are at the forefront of the regulatory approval process. Apart from Pfizer, American company Moderna and British company AstraZeneca and Oxford University have also announced the results of Phase-3 trials of their vaccine. Pfizer has also applied for approval in the US. The process of applying the vaccine to high-risk patients has already started even before the results of Phase-3 trials in China and Russia. For this, China has given emergency approval to four vaccines and Russia two.
UK regulator will investigate the results of the Oxford vaccine
The British government has formally asked the country's drug regulator to examine the Phase-3 results of AstraZeneca and Oxford University's vaccine-Kovyshield. The British government has taken this step amid questions arising over the initial results of the trials. Earlier, the UK government had also instructed the medical regulator to check the efficacy of Pfizer's vaccine. The drug regulator says that any vaccine will be approved even after meeting the criteria on the issue of safety, quality, and affixation.
AstraZeneca will conduct a new global clinical trial
AstraZeneca said it would conduct a global clinical trial to see its vaccine affixation. However, regulatory approval in the UK or EU will not be delayed. There may be a delay in seeking approval from the USFDA for vaccines in the US. During the trials, 2,741 volunteers received half + one dose, while 8,895 people received two full doses. In such a situation, the company faced difficulties in proving effectiveness in the group.
Russian vaccine will remain effective with Oxford vaccine
Russia's Gamalaya Research Institute has claimed that its Sputnik V vaccine may increase Astyzyneca-Oxford's CoviShield's Efficacy. Gamalaya Institute said on social media - "Oxford's two full dose affixes have been 62%. If new clinical trials begin, we suggest Sputnik V Human Adenoviral Vector Shot with Kovyshield, this will increase the Efficiency Two. Adding the vaccine can lead to significant re-vaccination results. "
Pfizer vaccine will be approved in Canada in December
Canadian drug regulator, Health Canada, has said it will approve Pfizer-BioNotech's COVID-19 vaccine around December. Supriya Sharma, Senior Medical Advisor at Health Canada, said that the vaccine has been at the forefront of Health Canada's review. A final decision on Pfizer's vaccine may also be taken in Canada's neighboring country of America in December and it can be approved for emergency use.
Electronic machines were sent to the polling stations at 7 am tomorrow
Voting begins at 7 a.m. tomorrow in 1,374 wards in the metropolitan area, 3,843 wards in the municipal area, and 7,621 wards in the metropolitan area.
MP Election 2023: 'Congress leaders in Madhya Pradesh are tearing each other's clothes', PM Modi taunts from Satna
The Prime Minister's vigorous rallies are continuing in the election state Madhya Pradesh. PM Modi today addressed a huge public meeting in Satna of the state. While addressing the people, the PM said
ICU can be reached only after eating Golgappa: Restrictions in Nepal; If the alert is not given then its sour and green water can also kill
There will hardly be anyone who does not like golgappas. I find golgappas from roadside handcarts tastier than the golgappas found in big restaurants and hotels. If you also eat golgappas daily on the
Runway 34: Why did Ajay Devgn take over the direction of 'Runway 34'? The actor revealed before the release
After minor roles in Gangubai Kathiawadi and RRR, Ajay Devgn is now coming up with the full film Runway 34, which releases in theaters on the 29th of this month. This is Ajay's first film in the year
MSP Committee: United Kisan Morcha rejected the MSP committee, questioning the inclusion of supporters of agricultural laws in the committee
The United Kisan Morcha has raised questions on the Minimum Support Price (MSP) committee constituted by the central government. The United Kisan Morcha dismissed the government's committee on minimum
Australia will check the visa of Khalistanis: Movement of separatist leaders will be monitored, and anti-India propaganda will also be monitored
The government there is now preparing to take strict action on anti-India activities in Australia. A meeting was held in Australia's capital Canberra regarding the Khalistani conspiracies against
Nobel Peace Prize: US-Russian journalists got respect, played an important role in protecting freedom of expression
The Nobel Peace Prizes for 2021 have been announced. This time the Nobel Committee has chosen two journalists for this honor. One of them is American journalist Maria Resa, founder of Rappler Media
The capital turned into a gas chamber: Poison mixed in the air of Delhi again, and AQI crossed 400 in many areas.
The level of pollution has been continuously increasing since Diwali in the country's capital Delhi. People are having trouble breathing. A day before Diwali, the Air Quality Index (AQI) in Delhi had
PM Kisan Scheme: The wait of crores of farmers is about to end, big update brought about the 11th installment of the scheme
A big update has come for the farmers waiting for the 11th installment of Pradhan Mantri Kisan Samman Nidhi Yojana. In early May, some reports said that the installment may arrive in the farmers'
Kolkata Doctor Case: SC to hear rape-murder case today, apex court may expand the scope of judicial investigation
The Supreme Court will hear the case of rape and murder of a trainee doctor at Kolkata's RG Kar Medical College and Hospital today. The apex court has taken suo motu cognizance of the case of rape and
